A system and method for metered dosage illumination in a bioanalysis or other system. In accordance with an embodiment, an illumination system or subsystem is described that can provide optimized amounts of excitation light within the short exposure times necessary to measure fast biological activity. The amount of light can be precisely measured to provide quantitative results. The light flux can also be precisely controlled to generate only a prescribed minimum amount of light, in order to reduce adverse lighting effects on both fluors and samples. Although the examples herein illustrate the providing of metered dosage illumination in the context of a bioanalysis system, the techniques can be similarly used to provide metered dosage illumination in the context of other types of system. In accordance with various embodiments, the technique is particularly useful in any quality-control, analysis, or assessment-based environment. Typical research and development applications can include quality control, instrument calibration, and light output standardization; while clinical and diagnostics applications can include clinical monitoring, bioassay calibration and control for diagnostics, treatment and or therapeutic evaluation.

Patent
   9658160
Priority
Jan 14 2011
Filed
Apr 11 2016
Issued
May 23 2017
Expiry
Jan 14 2031
Assg.orig
Entity
Small
1
238
window open
1. A system for providing metered dosage illumination for use in a bioanalysis or other system, comprising:
a light engine including a plurality of color channels wherein each color channel includes an led light source, a band pass filter, and an electronic circuit to power the led light source, whereby each color channel provides light of a different specific wavelength band;
an optical system comprising a plurality of reflective elements internal to the system configured to direct light from each color channel into a light beam;
a beam splitter positioned in the light beam and configured to split said light beam into an output light beam for illuminating said sample and a redirected light beam internal to the system;
a light-to-frequency converter positioned internal to the system to receive said redirected light beam from the beam splitter and generate a pulse train having a frequency proportional to an intensity of said redirected light beam;
a counter that maintains a count of pulses in the pulse train when a particular color channel of the plurality of color channels is turned on and turns off the particular color channel when the count of pulses reaches a reference count.
11. A method for providing metered dosage illumination in a bioanalysis or other system, comprising:
providing a light engine comprising,
a plurality of color channels wherein each color channel includes an led light source, a band pass filter, and an electronic circuit to power the led light source, whereby each color channel provides light of a different specific wavelength band,
an optical system comprising a plurality of reflective elements internal to the system configured to direct light from each color channel into a light beam,
a beam splitter positioned in the light beam and configured to split said light beam into an output light beam for illuminating said sample and a redirected light beam internal to the system,
a light-to-frequency converter positioned internal to the system to receive said redirected light beam from the beam splitter, and
a counter
turning on a particular color channel of the plurality of color channels;
generating with the light-to-frequency converter a pulse train having a frequency proportional to an intensity of said redirected light beam;
maintaining with the counter a count of pulses in the pulse train; and
turning off the particular color channel when the count of pulses reaches a reference count.
2. The system of claim 1, wherein said plurality of color channels comprises at least four color channels selected from violet, blue, cyan, teal, green, red, and yellow, such that each of the four color channels provides light of a selected intensity and a different specific wavelength band suitable for exciting a fluorescent molecule, and wherein the plurality of color channels includes at least four solid state light sources and at least four band pass filters.
3. The system of claim 1, wherein said plurality of color channels comprises at least five color channels selected from violet, blue, cyan, teal, green, red, and yellow, such that each of the five color channels provides light of a selected intensity and a different specific wavelength band suitable for exciting a fluorescent molecule, and wherein the plurality of color channels includes at least five solid state light sources and at least five band pass filters.
4. The system of claim 1, wherein the system further comprises a camera for imaging a sample exposed to the output light beam and wherein the system gates the camera off when the count of pulses reaches the reference count.
5. The system of claim 1, further comprising:
a camera for measuring fluorescence received from a sample in response to exposure of the sample to the output light beam;
a host computer for triggering an exposure period of said camera; and
wherein the system is configured to end the exposure period of said camera when the count of pulses reaches the reference count.
6. The system of claim 1, wherein the system is used as part of a bioanalysis system for one or more of: quantitative analyses, temporally fast analyses, fluorescence imaging, gene expression analysis, sequencing, high resolution fluorescence microscopy, fluorescence life time measurements, Førster Resonance Energy Transfer (FRET) Microscopy, and high content screening.
7. The system of claim 1, wherein the system further comprises:
a light detector for quantitative measurement of fluorescent light emitted by a sample in response to exposure of the sample to the output light beam; and
wherein the system is configured to turn on the light detector for quantitative measurements and gate the light detector off when the frequency detector count equals the reference count.
8. The system of claim 1, wherein turning off the particular color channel when the count of pulses reaches a reference count enables the system to control a light flux applied to a sample illuminated by the output beam in order to allow quantitative measurement of fluorescence produced by the sample in response to said light flux.
9. The system of claim 1, wherein turning off the particular color channel when the count of pulses reaches a reference count enables the system to control a light flux applied to a sample illuminated by the output beam in order to reduce photo-bleaching of the sample.
10. The system of claim 1, wherein turning off the particular color channel when the count of pulses reaches a reference count enables the system to control a light flux applied to a live cell sample illuminated by the output beam in order to reduce photo-toxic effects on the live cell sample.
12. The method of claim 11, wherein said plurality of color channels comprises at least four color channels selected from violet, blue, cyan, teal, green, red, and yellow, such that each of the four color channels provides light of a selected intensity and a different specific wavelength band suitable for exciting a fluorescent molecule, and wherein the plurality of color channels includes at least four solid state light sources and at least four band pass filters.
13. The method of claim 11, wherein said plurality of color channels comprises at least five color channels selected from violet, blue, cyan, teal, green, red, and yellow, such that each of the five color channels provides light of a selected intensity and a different specific wavelength band suitable for exciting a fluorescent molecule, and wherein the plurality of color channels includes at least five solid state light sources and at least five band pass filters.
14. The method of claim 11, further comprising:
measuring fluorescence received from a sample in response to exposure of the sample to the output light beam using a camera.
15. The method of claim 11, further comprising:
imaging a sample exposed to the output light beam with a camera; and
gating the camera off when the count of pulses reaches the reference count.
16. The method of claim 11 further comprising:
triggering an exposure period of a camera;
measuring with said camera fluorescence received from a sample in response to exposure of the sample to the output light beam; and
ending the exposure period of said camera when the count of pulses reaches the reference count.
17. The method of claim 11, further comprising:
turning on a light detector for quantitative measurements of fluorescent light emitted by a sample in response to exposure of the sample to the output light beam; and
gating the light detector off when the frequency detector count equals the reference count.
18. The method of claim 11, further comprising controlling a light flux applied to a sample illuminated by the output beam in order to allow quantitative measurement of fluorescence produced by the sample in response to said light flux.
19. The method of claim 11, further comprising controlling a light flux applied to a sample illuminated by the output beam in order to reduce photo-bleaching of the sample.
20. The method of claim 11, further comprising controlling a light flux applied to a live cell sample illuminated by the output beam in order to reduce photo-toxic effects on the live cell sample.

This application is a continuation of U.S. patent application Ser. No. 13/874,645, filed May 1, 2013 entitled “SYSTEM AND METHOD FOR CONTROLLED INTENSITY ILLUMINATION IN A BIOANALYSIS OR OTHER SYSTEM” and which is a continuation of U.S. patent application Ser. No. 13/282,108, filed Oct. 26, 2011 entitled “SYSTEM AND METHOD FOR METERED DOSAGE ILLUMINATION IN A BIOANALYSIS OR OTHER SYSTEM”, now U.S. Pat. No. 8,466,436 issued Jun. 18, 2013 and which application is a continuation-in-part of U.S. patent application Ser. No. 13/007,535, filed Jan. 14, 2011, now U.S. Pat. No. 8,389,957, issued Mar. 5, 2013, entitled “SYSTEM AND METHOD FOR METERED DOSAGE ILLUMINATION IN A BIOANALYSIS OR OTHER SYSTEM”, which is incorporated herein by reference.

A portion of the disclosure of this patent document contains material which is subject to copyright protection. The copyright owner has no objection to the facsimile reproduction by anyone of the patent document or the patent disclosure, as it appears in the Patent and Trademark Office patent file or records, but otherwise reserves all copyright rights whatsoever.

The invention is generally related to light sources, and bioanalytics or bioanalysis, and is particularly related to a system and method for metered dosage illumination in a bioanalysis or other system, including applications in research and development; and in clinical and diagnostic arenas.

Bioanalytics or bioanalysis is the analysis of biological samples. Bioanalysis systems often use light to excite fluorescence from molecular tags in a sample (referred to herein as fluorescent tags or fluors). Fluors may be exogenous, as in the case of fluorescently labeled immunochemical tags that recognize subcellular structure and bind to impose fluorescent labeling; or endogenous, as in the case of genetically modified cells in which fluorescent proteins for example are expressed in order to impart specific fluorescent signals within a living cell. Particularly in fields such as fluorescence imaging, gene expression analysis, various types of sequencing, high resolution fluorescence microscopy, fluorescence life time measurements, and high content screening, it is necessary to be able to measure the amount of fluorescence and compare that amount to other measurements. This means the excitation light flux must generally be measured for each illumination exposure or fluorescence excitation event. To monitor biological events, it is necessary to be able to measure specific biological activity with often sub-millisecond exposure times. Excitation and detection must occur rapidly, such that the illumination must be generally switched on and off within a time period that is at most one-tenth of the duration of the minimum exposure time. Additionally, fluors can be temporarily or permanently photo-bleached, and biological samples can be otherwise damaged by the illumination light—a process known as phototoxicity. In order to minimize perturbation of the fluors due to photo-bleaching, and photo-damage to the biological samples, it is generally desired to minimize the light flux or dosage within the constraints of the signal-to-noise (S/N) requirements of that particular bioanalysis system. These are the general areas that embodiments of the invention are intended to address.

Described herein is a system and method for metered dosage illumination in a bioanalysis or other system. In accordance with an embodiment, an illumination system or subsystem is described that can provide optimized amounts of excitation light within the short exposure times necessary to measure fast biological activity. The amount of light can be precisely measured to provide quantitative results. The light flux can also be precisely controlled to generate only a prescribed minimum amount of light, in order to reduce adverse lighting effects on both fluors and samples. Although the examples herein illustrate the providing of metered dosage illumination in the context of a bioanalysis system, the techniques can be similarly used to provide metered dosage illumination in the context of other types of system. In accordance with various embodiments, the technique is particularly useful in any quality-control, analysis, or assessment-based environment. Typical research and development applications can include quality control, instrument calibration, and light output standardization; while clinical and diagnostics applications can include clinical monitoring, bioassay calibration and control for diagnostics, treatment and or therapeutic evaluation.

FIG. 1 illustrates a system for metered dosage illumination, in accordance with an embodiment.

FIG. 2 illustrates an example of a graphical user interface (GUI), for use with a system for metered dosage illumination, in accordance with an embodiment.

FIG. 3 illustrates an example of an alternative graphical user interface (GUI), for use with a system for metered dosage illumination, in accordance with an embodiment.

FIG. 4 illustrates an example of a fluorescence lifetime imaging microscopy (FLIM) technique, in accordance with an embodiment.

FIG. 5 illustrates an embodiment of an analog measurement of dosage, in accordance with an embodiment.

FIG. 6 illustrates how the system can be used to provide constant current dosage illumination, in accordance with an embodiment.

FIG. 7 illustrates how the system can be used to provide metered dosage illumination, in accordance with an embodiment.

FIG. 8 illustrates how the system can be used to provide constant intensity illumination, in accordance with an embodiment.

As described above, in the context of bioanalysis, it is often required that an excitation light flux be measured for each illumination exposure or fluorescence excitation event; or that the illumination be switched on and off within an appropriately brief time period; or that the light flux or dosage be minimized within the constraints of the signal-to-noise (S/N) requirements of the particular bioanalysis system.

To address this, described herein is a system and method for metered dosage illumination in a bioanalysis or other system. In accordance with an embodiment, an illumination system or subsystem is described that can provide optimized amounts of excitation light within the short exposure times necessary to measure fast biological activity. The amount of light can be precisely measured to provide quantitative results. The light flux can also be precisely controlled to generate only a prescribed minimum amount of light, in order to reduce adverse lighting effects on both fluors and samples. In accordance with various embodiments, the technique is particularly useful in any quality-control, analysis, or assessment-based environment. Typical research and development applications can include quality control, instrument calibration, and light output standardization; while clinical and diagnostics applications can include clinical monitoring, bioassay calibration and control for diagnostics, treatment and or therapeutic evaluation.

FIG. 1 illustrates a system for metered dosage illumination, in accordance with an embodiment. As shown in FIG. 1, in accordance with an embodiment, the system 102 comprises a multi-color light engine 104 that can provide a plurality of different colors of light as a light output 106, to excite various fluorescent markers in a sample 108. An example of such a light engine can be the SPECTRA series of light engines supplied by Lumencor, Inc.

A host computer 110 generates an analysis protocol, including providing a dosage for each of the plurality of colors, and receiving feedback data from a camera 112. In accordance with an embodiment, the dosage can be in the form of a reference count that represents the amount of light flux per exposure period for each color provided by the light engine.

The camera is configured to detect fluorescence from the sample.

A beamsplitter 114 directs a portion of the light engine output, from the light engine, to a photodiode detector 116. A light-to-frequency converter 118 converts the detector output to a pulse train 130, the frequency of which is proportional to the light flux. A microprocessor-based counter 120 counts the pulse train, for each color, and compares the ongoing count to the reference count or preset dosage for each color.

Depending on the particular implementation, the above components can be provided as part of a complete system; or alternatively some or all of the above components can be provided as part of an illumination subsystem. For example, in accordance with an embodiment, the multi-color light engine, beamsplitter, photodiode detector, light-to-frequency converter, and microprocessor-based counter components can be provided as an illumination subsystem intended for use with a separately-provided host computer and camera.

In accordance with an embodiment, during operation of the system, the host computer downloads a reference count 122 for each color to the microprocessor-based counter. For each exposure period, the computer triggers the camera to begin an exposure period 124. The camera then sends an enable message or otherwise enables 126 the light engine, to turn on the appropriate color, and begins integrating the fluorescence. A portion of the light engine output 128, as directed by the beamsplitter, is monitored by the photodiode detector. The detector's output is converted to the pulse train that is then counted by the counter. When the counter reaches the reference count, it disables 132 the color channel currently on or provided by the light engine. Simultaneously, another trigger 134 is sent to the camera, ending the current exposure period.

The above approach avoids the latency inherent in any non-real-time operating systems. In accordance with an embodiment, additional circuitry can be provided to determine which color should be activated, and eliminate any delay inherent in the light engine turning on a color channel. An alternative approach is for the computer to turn on each color directly in conjunction with starting the camera's exposure period. In yet other embodiments, the procedure described above can be modified to suit the particular needs of the system (such as its use in quantitative analyses, or temporally fast analyses, as described below).

FIG. 2 illustrates an example of a graphical user interface (GUI) 142, for use with a system for metered dosage illumination, in accordance with an embodiment. As shown in the example of FIG. 2, the GUI allows an operator to set and to monitor dosage counts in each of the plurality of colors that can be provided by the light engine.

FIG. 3 illustrates an example of an alternative graphical user interface (GUI) 144, for use with a system for metered dosage illumination, in accordance with an embodiment. In the example shown in FIG. 3, the GUI controls power levels and exposure times. For each color channel, the operator can enter the relative power levels, maximum dosage frequency and approximate exposure period. In accordance with an embodiment, the system, or software therein, calculates the required dosage or reference count by multiplying the frequency by the desired exposure time. The exposure time is approximate, since the intensity can change resulting in shorter or longer exposure periods, but still yielding the same metered dosage for each period. If the power level is reduced (for example, by half) the dosimeter frequency is similarly reduced by half assuming a linear response. For the same exposure period the calculated dosage is reduced by half.

Quantitative Analysis

In accordance with an embodiment of particular use in quantitivate analysis, the system can comprise a collection of color channels, wherein each color channel is used to provide the specific wavelength band needed to excite a specific fluorescence molecule as defined by the fluorescence absorption of the tag. In accordance with an embodiment, each color channel can comprise a solid state light source (e.g. an LED, laser, light pipe or other light source), a single band pass filter, and an electronic circuit to power the light source. Within the system, the channels can be combined using, e.g. dichroic mirrors, so that the light from each source travels the same optical path, which is required, e.g. in epifluorescence measurements.

In accordance with an embodiment, the control circuitry can use a photodiode to measure the excitation light flux from each channel during each exposure period. An example of such a photodiode can be the TAOS light-to-frequency converter (part number TSL230RD), which can be used to quantify the light flux or dosage for each illumination pulse. The converter circuit generates pulses at a rate that is proportional to the light flux. Counting the pulses yields a measure of the dosage during each exposure time. Since dosage measurements can be made for each color channel independently, the user can optimize the amount of light, using a GUI such as that described above, to irradiate any given fluor uniquely. This allows for differences in efficiencies of all the processes involved in fluorescent signal generation to be taken into account for each color channel, (e.g. efficiency of light generation, fluorescence generation, or various differences in biological sample condition and fluor concentration).

In accordance with an embodiment, quantitative fluorescent measurements can be obtained ratiometrically by measuring the fluorescent signal, and dividing that signal by the dosage. In this manner, the fluorescent measurements can be normalized and rendered independent of the illumination intensity. This approach can be further automated by using dosage measurements to control the timing of the illumination and detection events. For example in accordance with an embodiment, a desired dosage count for each color channel can be entered into a reference counter. During a measurement, the control electronics monitor the dosage and gate off the excitation source for each color when the dosage count equals the amount in the reference counter. Light is metered independently of the exposure time period, rather as a function of the total light delivery prescribed by the reference counter. The precise dosage is delivered during each exposure, leading to quantitation as precise as the light flux measurement.

In this way, quantitative analysis can be performed using metered dosage with or without constant exposure times. In the former case, the light flux is maintained at the same level, and the flux is delivered within the exposure period. After the metered light dosage has been delivered, the excitation light is gated off leaving a time period when the camera can still detect fluorescent signals. In the latter case, the light flux is held constant, and the exposure time will vary as the intensity fluctuates.

In accordance with an embodiment, a range of light levels can be monitored and measured using conventional counters and logic circuitry. In some instances, the dosage levels may be so small as to generate insufficient statistical counts or too large and can overflow the counters. In these instances, a programmable gain can be used to dynamically adjust the count rate from the dosimeter circuitry.

Temporally Fast Analysis

In accordance with an embodiment of particular use in temporally fast analysis, the sources and circuitry can be implemented for fast switching, as is common with LEDs, lasers and light pipes. For example, in accordance with these embodiments, all switching can be performed electronically, with no mechanical motion. This allows modulation in the range of 10 s to 1 ms to be readily achieved. In addition, significant speed increases can be achieved by directly connecting the camera and the illumination subsystem. In accordance with this embodiment, the host computer can trigger the camera to begin the analysis. The camera in turn can send a trigger to the illumination subsystem to turn on the excitation light. When the dosage count equals the reference count, the light is gated off, and a signal is sent to the camera to end the exposure. This configuration eliminates the variability in timing associated with non-real-time operating systems.

The illumination subsystem can also be used as a direct connection to drive the camera to activate or advance. Color channels can be programmed, e.g. via a ring buffer, to engage camera operation uniquely for each fluor of interest, each excitation source in a preprogrammed series of exposures of the various color channels. The timing of such camera and/or illuminator pulses can be optimized to interrogate specialized fluor characteristics, such as for fluorophor lifetime measurements, photoactivation and photolysis measurements as examples.

Photo-Bleaching and Phototoxicity

In accordance with another embodiment, the ability to precisely meter the light dosage and precisely turn on and off the illumination can minimize overall the exposure of the biological sample to the illuminator's excitation light. In so doing, photo-bleaching and phototoxicity effects are reduced, sample viability for live cell analyses is prolonged, and artifacts imposed by the lighting on the measurement are reduced. The combined benefit of such dosage optimization is enhanced accuracy and longer duration quantitative fluorescent analyses.

Modulation Techniques

As described above, in accordance with an embodiment, a metered dosage technique can be used to obtain pulse-to-pulse repeatability and increase dynamic range. This technique involves gating the light on and off for the required dosage during each camera exposure period. Other modulation techniques can be used, e.g., Förster (or Fluorescence) Resonance Energy Transfer (FRET); or fluorescence lifetime imaging microscopy (FLIM), wherein the illumination is modulated, and the fluorescence lifetime is determined by the phase shift and modulation depth of the fluorescence signal relative to the illumination signal. FIG. 4 illustrates an example of a fluorescence lifetime imaging microscopy (FLIM) technique 146, in accordance with an embodiment.

Analog Measurement Techniques

As described above, in accordance with an embodiment, a host computer can be used to generate an analysis protocol, including providing a dosage for each of the plurality of colors, and receiving feedback data from a camera, while a microprocessor-based counter counts the pulse train, and compares the ongoing count to the reference count or preset dosage for each color. in accordance with other embodiments, alternative measurement techniques, such as analog measurement techniques can be used. FIG. 5 illustrates an embodiment 152 which provides an analog measurement of dosage, in accordance with an embodiment. As shown in FIG. 5, the current output of a photodiode (PD) 154 can be fed to a transimpedance amplifier (TIA) 156, and converted to a voltage. This voltage signal can be integrated by the integrator opamp (∫) 158. The comparator (=) 160 compares the integrator output to a target reference level equal to the desired dosage. When the two values are the same, the comparator can generate a signal 162, turning off the light engine.

Use Cases

In accordance with an embodiment, the light engine can be operated in different modes, i.e. the output of the light engine can be controlled using a variety of different mechanisms, to satisfy particular use cases. This enables the light engine to be particularly useful in, e.g. quality-control, analysis, or assessment-based environments.

For example, although some light engines might provide an open loop option, in which output power information is readable on a monitor, such information is generally not fed back to any controller internal to the light engine. Although the current may be constant, there is no feedback mechanism on the power delivered, so the outputs are susceptible to a variety of atmospheric changes. In accordance with an embodiment, the use of a closed-loop option is beneficial not only for controlling inter-assay reproducibility, but also for monitoring inter-instrument reproducibility. For example, using a metered dosage approach, an entity can calibrate all of their light engines for all instrument products to deliver the same output power at a particular setting.

As another example, in analytical and clinical testing facilities, applications such as bioassay development, quality control in assay development and reagent formulation, clinical screening, diagnostics, treatment and therapeutic evaluation, and other analytical and bioanalytical endeavors, require that intra-assay control, as well as inter-instrument control, be robust and reproducible. This ensures that multiple instruments (e.g., readers, scanners and hand held analysis tools) processing the same or similar analyses will yield equivalent results in terms of the signal generated for similarly performed procedures. In turn, this requires the instrument performance itself to be well behaved and reproducible, which can only be accomplished in light-dependent bioanalytical equipment if the illumination can be controlled and identical for all instruments. In accordance with an embodiment, a metered dosage approach can be used to enable this type of quality control. In particular, the output of each instrument can be calibrated to, e.g. a NIST traceable standard, and the dosage required to achieve this power level can be recorded. Then, this identical light flux dosage, or an amount proportional to this dosage, can be delivered for each exposure for each instrument, or among different instruments within a family of analysis tools.

Use Case—Constant Current

In accordance with an embodiment, in a constant current mode, the light engine's circuitry monitors the current through each light source and keeps that constant. The amount of current can be sensed by measuring a voltage drop across a calibrated resistor. Once thermalized, the power output is constant for a constant ambient temperature and pressure, and the pulse-to-pulse reproducibility is better than 99%. This is a suitable option in a well-controlled environment with no thermal changes or warm up times. However, outputs can fluctuate as a function of warm up, duty cycle, power level and atmospheric conditions.

FIG. 6 illustrates how the system can be used to provide constant current dosage illumination, in accordance with an embodiment. As shown in FIG. 6, the system 170 can be provided similarly to that shown in FIG. 1 above. When a constant current mode is used, the light engine's current monitoring circuit 172 monitors the current through each light source and keeps that constant, to provide a constant current light output 176 of generally constant dosage 176 (subject to the considerations of warm up, duty cycle, power level and atmospheric conditions, as described above).

Use Case—Metered Dosage

In accordance with an embodiment, in a metered dosage mode, the system monitors a portion of the light engine output beam, internal to the light engine, using a light-to-frequency converter or circuitry, similar to that described above. The output of this circuitry is a pulse train which is fed to a counter. When the counter reaches the desired count or dosage, the light exposure is terminated. The total integrated light flux or dosage can be regulated to be the same for each camera exposure or defined detection period. This means that, although the time period that the light source is on may vary slightly, the number of counts does not. The output can be locked into the photon number, and the resultant dosage is not susceptible to warm up time, duty cycle, power level or changes in atmospheric conditions.

FIG. 7 illustrates how the system can be used to provide metered dosage illumination, in accordance with an embodiment. As shown in FIG. 7, the system 180 can again be provided similarly to that shown in FIG. 1 above. When a metered dosage mode is used, the system monitors a portion of the light engine output beam, internal to the light engine, using a light-to-frequency converter or circuitry, and regulates the light output 182 to be the same count 184, 186, 189 for each camera exposure or defined detection period, so that, although the time period that the light source is on may vary slightly, the number of counts does not.

Use Case—Constant Intensity

In accordance with an embodiment, in a constant intensity mode, the light engine can include a circuitry that monitors the light output, and adjusts the intensity levels in real time. This mode is particularly useful in rolling shutter camera applications. Limitations of this approach versus, e.g. the metered dosage approach described above, include that there may be a compromise in the maximum power or intensity deliverable because some headroom is needed in order to offset the anticipated fluctuations; exposure times will generally be longer; and the dynamic range of the final instrument will be smaller than that for an instrument controlled by metered dosage. The accuracy of the light engine calibration will also be somewhat lower than that for metered dosage, because the sensor response will fluctuate due to atmospheric conditions.

FIG. 8 illustrates how the system can be used to provide constant intensity illumination, in accordance with an embodiment. As shown in FIG. 8, the system 190 can again be provided similarly to that shown in FIG. 1 above. When a constant intensity mode is used, a light intensity monitoring/adjusting circuit 192 monitors the light output 194, and adjusts the intensity levels of one or more sources 196, 197 in real time.

The present invention may be conveniently implemented using one or more conventional general purpose or specialized digital computers or microprocessors programmed according to the teachings of the present disclosure. Appropriate software coding can readily be prepared by skilled programmers based on the teachings of the present disclosure, as will be apparent to those skilled in the software art.

In some embodiments, the present invention includes a computer program product which is a storage medium (media) having instructions stored thereon/in which can be used to program a computer to perform any of the processes of the present invention. The storage medium can include, but is not limited to, any type of disk including floppy disks, optical discs, DVD, CD-ROMs, microdrive, and magneto-optical disks, ROMs, RAMs, EPROMs, EEPROMs, DRAMs, VRAMs, flash memory devices, magnetic or optical cards, nanosystems (including molecular memory ICs), or any type of media or device suitable for storing instructions and/or data.

The foregoing description of the present invention has been provided for the purposes of illustration and description. It is not intended to be exhaustive or to limit the invention to the precise forms disclosed. In particular, although most of the examples above illustrate the providing of metered dosage illumination in the context of a bioanalysis system, the techniques can be similarly used to provide metered dosage illumination in the context of other types of systems. The embodiments were chosen and described in order to best explain the principles of the invention and its practical application, thereby enabling others skilled in the art to understand the invention for various embodiments and with various modifications that are suited to the particular use contemplated. It is intended that the scope of the invention be defined by the following claims and their equivalents.

Larsen, David, Jaffe, Claudia B, Jaffe, Steven M

Patent Priority Assignee Title
10753794, May 28 2015 Empire Technology Development LLC Concurrent activation of multiple illumination sources for sample analysis
Patent Priority Assignee Title
1998054,
3313337,
3637285,
3759604,
3881800,
3982151, Oct 23 1967 Corning Glass Works Optical information storage system
4003080, Jun 02 1975 Laser Video, Inc. Large screen video display systems and methods therefor
4298820, Jun 26 1978 U.S. Philips Corporation Luminescent screen
4371897, Sep 02 1980 Xerox Corporation Fluorescent activated, spatially quantitative light detector
4510555, Feb 27 1984 Ornamental lighting device
4539687, Dec 27 1982 AT&T Bell Laboratories Semiconductor laser CRT
4602281, Sep 05 1983 Olympus Optical Co., Ltd. Automatic means for controlling dosage of illuminating light for picking-up image by endoscope assembly
4626068, Jul 29 1982 The United States of America as represented by the Secretary of the Air Photoactive coating for hardening optical fibers
4642695, Nov 04 1983 Mitsubishi Denki Kabushiki Kaisha Projection cathode-ray tube having enhanced image brightness
4644141, Oct 12 1984 Dragerwerk AG Infrared radiator
4657013, Mar 25 1985 Carl-Zeiss-Stiftung Illuminance dosage device for an operation microscope
4695332, Dec 27 1982 American Telephone and Telegraph Company, AT&T Bell Laboratories Method of making a semiconductor laser CRT
4695732, May 18 1984 U S PHILIPS CORPORATION, 100 E 42ND STREET, NEW YORK, NY 10017 A CORP OF DE Electron lithography apparatus
4695762, Jun 28 1985 American Telephone and Telegraph Company, AT&T Bell Laboratories Electron beam pumped rod-like light emitters
4713577, Dec 20 1985 ALLIED CORPORATION, A CORP OF NEW YORK Multi-layer faceted luminescent screens
4724356, Oct 10 1986 Lockheed Martin Corporation Infrared display device
4798994, Sep 05 1986 U S PHILIPS CORPORATON, A CORP OF DE Low reflectance display device
4804850, Mar 14 1986 LUMINIS PTY LIMITED, A CORP OF SOUTH AUSTRALIA Measurement of fluorescence
4852985, Oct 16 1986 Olympus Optical Co., Ltd. Illuminating device for microscopes
4937661, Jul 11 1988 North American Philips Corporation Projection television display tube and device having band pass interference filter
4995043, Mar 24 1989 Matsushita Electric Industrial Co., Ltd. Thin-film electroluminescence apparatus including optical interference filter
5052016, May 18 1990 Science & Technology Corporation @ UNM Resonant-periodic-gain distributed-feedback surface-emitting semiconductor laser
5089860, Jun 25 1990 Board of Regents, The University of Texas System Quantum well device with control of spontaneous photon emission, and method of manufacturing same
5109463, Jun 25 1990 Fiber optic lamp
5126626, Mar 29 1990 Mitsubishi Denki Kabushiki Kaisha Projection cathode ray tube
5128846, Oct 23 1990 International Business Machines Corporation Light source
5137598, Jun 04 1990 ITT Corporation Thin film phosphor screen structure
5193015, Oct 05 1989 Thorn EMI plc Cholesteric liquid crystal screen which reflects substantially all of the projected light
5200861, Sep 27 1991 3M Innovative Properties Company Lens systems
5226053, Dec 27 1991 AGERE Systems Inc Light emitting diode
5231533, Feb 15 1991 JSR Corporation Nonlinear optical element and uses thereof
5233372, Oct 16 1990 Canon Kabushiki Kaisha Illuminating optical device
5249195, Jun 30 1992 AT&T Bell Laboratories Erbium doped optical devices
5285131, Dec 03 1990 University of California Vacuum-sealed silicon incandescent light
5289018, Aug 14 1990 Canon Kabushiki Kaisha Light emitting device utilizing cavity quantum electrodynamics
5312535, Jul 17 1992 Beckman Instruments, Inc.; BECKMAN INSTRUMENTS, INC A CORP OF DE Capillary electrophoresis detection
5315128, Apr 30 1993 AT&T Bell Laboratories Photodetector with a resonant cavity
5332892, Jul 25 1991 Symbol Technologies, Inc. Optical systems for bar code scanners
5345333, Apr 19 1991 MICRO SCIENCE TECHNOLOGIES Illumination system and method for a high definition light microscope
5363398, Sep 30 1993 AT&T Bell Laboratories Absorption resonant rare earth-doped micro-cavities
5416342, Jun 23 1993 Cree, Inc Blue light-emitting diode with high external quantum efficiency
5416617, Nov 22 1991 Thomson-CSF Image projection display screen employing polymer dispersed liquid crystal layer and electrochromic layer
5418584, Dec 31 1992 Honeywell INC Retroreflective array virtual image projection screen
5428476, Apr 07 1994 Stewart Filmscreen Corporation Wide angle rear projection lenticular lens system
5469018, Jul 20 1993 QUANTUM VISION, INC Resonant microcavity display
5475281, Feb 25 1991 U.S. Philips Corporation Cathode
5478658, May 20 1994 AGERE Systems Inc Article comprising a microcavity light source
5489771, Oct 15 1993 University of Virginia Patent Foundation LED light standard for photo- and videomicroscopy
5493177, Dec 03 1990 Regents of the University of California, The Sealed micromachined vacuum and gas filled devices
5500569, Apr 07 1993 Instrumentarium Oy; Vaisala Oy Electrically modulatable thermal radiant source and method for manufacturing the same
5542016, May 05 1993 Motorola, Inc. Optical fiber light emitting apparatus
5616986, Jul 20 1993 QUANTUM VISION, INC Resonant microcavity display
5644676, Jun 23 1994 Instrumentarium Oy; Vaisala Oy Thermal radiant source with filament encapsulated in protective film
5658976, Dec 14 1994 BASF Corporation Pacification of optically variable pigments for use in waterborne coating compositions
5669692, Nov 17 1995 Timex Corporation Fiber optic lighting system
5671050, Nov 07 1994 Zygo Corporation Method and apparatus for profiling surfaces using diffracative optics
5674698, Sep 14 1992 Sarnoff Corporation Up-converting reporters for biological and other assays using laser excitation techniques
5690417, May 13 1996 Optical Gaging Products, Inc. Surface illuminator with means for adjusting orientation and inclination of incident illumination
5715083, Jun 27 1994 PANASONIC LIQUID CRYSTAL DISPLAY CO , LTD Screen for liquid crystal projector
5719391, Dec 08 1994 INTEGENX INC Fluorescence imaging system employing a macro scanning objective
5757014, Apr 07 1995 Novartis Corporation Optical detection device for analytical measurement of chemical substances
5781338, Nov 17 1994 Carl Zeiss Stiftung Microscope stage
5803579, Jun 13 1996 Gentex Corporation Illuminator assembly incorporating light emitting diodes
5804919, Jul 20 1994 QUANTUM VISION, INC Resonant microcavity display
5808759, Nov 30 1995 Mitsubishi Denki Kabushiki Kaisha Projection type display including a holographic diffuser
5827438, Nov 24 1995 Vaisala Oy Electrically modulatable thermal radiant source with specific filament
5833827, Sep 29 1995 Hitachi, Ltd. Capillary array electrophoresis system
5858562, Oct 13 1994 SAMSUNG DISPLAY CO , LTD Organic thin film electroluminescent device
5864426, Nov 13 1995 MAGMA, INC Apparatus and method for increasing blue component gain from a video projection screen
5942319, Dec 13 1994 Asahi Glass Company Ltd Light absorptive antireflector
5955839, Mar 26 1997 Quantum Vision, Inc.; QUANTUM VISION, INC Incandescent microcavity lightsource having filament spaced from reflector at node of wave emitted
5984861, Sep 29 1997 Boston Scientific Corporation Endofluorescence imaging module for an endoscope
6110106, Jun 24 1998 LED MEDICAL DIAGNOSTICS, INC Endoscopes and methods relating to direct viewing of a target tissue
6154282, Oct 26 1998 Carl Zeiss Microscopy GmbH Semiconductor based excitation illuminator for fluorescence and phosphorescence microscopy
6198211, May 06 1998 QUANTUM VISION, INC Resonant microcavity display
6204971, May 14 1999 3M Innovative Properties Company Glass microspheres for use in films and projection screen displays and methods
6222673, Aug 18 1998 Coherent, Inc Group-delay-dispersive multilayer-mirror structures and method for designing same
6293911, Nov 20 1996 Olympus Optical Co., Ltd. Fluorescent endoscope system enabling simultaneous normal light observation and fluorescence observation in infrared spectrum
6299338, Nov 30 1998 General Electric Company Decorative lighting apparatus with light source and luminescent material
6304584, Nov 06 1998 Lawrence Livermore National Security LLC Blue diode-pumped solid-state-laser based on ytterbium doped laser crystals operating on the resonance zero-phonon transition
6366383, Feb 18 1999 Carl Zeiss Jena GmbH Relay optics for a deflection system, and a deflection system
6392341, Jul 20 1994 QUANTUM VISION, INC Resonant microcavity display with a light distribution element
6404127, Jul 20 1994 QUANTUM VISION, INC Multi-color microcavity resonant display
6404495, Mar 12 1997 Corning Applied Technologies Corporation System and method for molecular sample measurement
6422994, Sep 24 1997 Olympus Optical Co., Ltd. Fluorescent diagnostic system and method providing color discrimination enhancement
6444476, May 29 1998 Photonic Research Systems Limited Luminescence assay using cyclical excitation wavelength sequence
6513962, Dec 17 1998 MAQUET SAS Illumination system adapted for surgical lighting
6517213, Mar 31 1997 Idec Izumi Corporation Indicator device and illumination device
6529322, Jan 27 1999 QUANTUM VISION, INC High contrast front and rear viewing surfaces for projection displays
6542231, Aug 22 2000 Thermo Finnigan LLC Fiber-coupled liquid sample analyzer with liquid flow cell
6544734, Oct 09 1998 Motorola, Inc Multilayered microfluidic DNA analysis system and method
6594075, Nov 29 1999 Olympus Corporation Microscope with electronic image sensor
6608332, Jul 29 1996 Nichia Corporation Light emitting device and display
6614161, Jul 20 1993 QUANTUM VISION, INC Resonant microcavity display
6614179, Jul 29 1996 Nichia Corporation Light emitting device with blue light LED and phosphor components
6637905, Sep 26 2002 Taiwan Semiconductor Manufacturing Company, Ltd Method and system for providing backlighting utilizing a luminescent impregnated material
6642652, Jun 11 2001 Lumileds LLC Phosphor-converted light emitting device
6649432, Oct 25 1999 QUANTUM VISION, INC Resonant microcavity display utilizing mirrors exhibiting anomalous phase dispersion
6674575, Apr 27 1999 Carl Zeiss Microscopy GmbH Transmitted light/lighting device for microscopes
6680569, Feb 18 1999 Lumileds LLC Red-deficiency compensating phosphor light emitting device
6685341, Apr 06 1994 3M Innovative Properties Company Light fixture having a multilayer polymeric film
6690467, May 05 2000 Applied Biosystems, LLC Optical system and method for optically analyzing light from a sample
6717353, Oct 14 2002 Lumileds LLC Phosphor converted light emitting device
6747710, Dec 03 2001 INTERDIGITAL CE PATENT HOLDINGS Light valve projector architecture
6791259, Nov 30 1998 ALLY BANK, AS COLLATERAL AGENT; ATLANTIC PARK STRATEGIC CAPITAL FUND, L P , AS COLLATERAL AGENT Solid state illumination system containing a light emitting diode, a light scattering material and a luminescent material
6791629, Nov 09 2000 3M Innovative Properties Company Lens systems for projection televisions
6795239, Apr 27 1999 Carl Zeiss Microscopy GmbH Transmitted light/lighting device for microscopes
6843590, May 17 2000 QUANTUM VISION, INC Waveguide based light source
6869206, May 23 2003 Illumination systems utilizing highly reflective light emitting diodes and light recycling to enhance brightness
6870165, Oct 19 2001 Qiagen Sciences, LLC Multi-color multiplexed analysis in a bio-separation system
6926848, Jun 13 2001 Rhodia Electronics & Catalysts Compound based on an alkaline-earth metal, sulphur and aluminium, gallium or indium, its method of preparation and its use as a phosphor
6958245, Apr 25 1996 BIOARRAY SOLUTIONS LTD Array cytometry
6960872, May 23 2003 Goldeneye, Inc. Illumination systems utilizing light emitting diodes and light recycling to enhance output radiance
6981970, Dec 16 2002 Alma Lasers Ltd; ALMA LASER LTD Device and method for treating skin
6991358, Dec 04 2002 Mitsubishi Electric Corporation Planar light source unit and display device
6995355, Jun 23 2003 ABL IP Holding LLC Optical integrating chamber lighting using multiple color sources
7009211, Oct 25 1999 Quantum Vision, Inc. Resonant microcavity display utilizing mirrors exhibiting anomalous phase dispersion
7011421, Oct 18 2001 LUMINII PURCHASER, LLC Illumination device for simulating neon lighting through use of fluorescent dyes
7035017, Apr 18 2003 Quantum Vision, Inc.; QUANTUM VISION, INC System and method for telecentric projection lenses
7083610, Jun 07 2000 Boston Scientific Scimed, Inc Device for irradiating tissue
7141801, Dec 26 2002 Leica Microsystems CMS GmbH System and method of illuminating living cells for imaging
7153015, Dec 31 2001 INNOVATIONS IN OPTICS, INC Led white light optical system
7192161, Oct 18 2001 LUMINII PURCHASER, LLC Fluorescent illumination device
7205048, Sep 17 2001 Life Technologies Corporation Functionalized fluorescent nanocrystal compositions and methods of making
7208007, Aug 07 2003 CUTERA, INC System and method utilizing guided fluorescence for high intensity applications
7211833, Jul 23 2001 CREE LED, INC Light emitting diodes including barrier layers/sublayers
7239449, Sep 10 2003 Sypro Optics GmbH Illumination module for color display
7300175, Dec 30 2002 INNOVATIONS IN OPTICS, INC. LED illuminator with retro reflector
7316497, Mar 29 2005 3M Innovative Properties Company Fluorescent volume light source
7384797, Oct 12 2000 University of Utah Research Foundation; UTAH RESEARCH FOUNDATION, UNIVERSITY OF Resonant optical cavities for high-sensitivity high-throughput biological sensors and methods
7416313, Mar 28 2003 Carl Zeiss Microscopy GmbH Assembly for illuminating objects with light of different wavelengths
7422356, Jun 13 2005 Nichia Corporation Light emitting device
7427146, Feb 11 2004 3M Innovative Properties Company Light-collecting illumination system
7445340, May 19 2005 3M Innovative Properties Company Polarized, LED-based illumination source
7467885, Apr 29 2003 OSRAM Opto Semiconductors GmbH; OSRAM OLED GmbH Light source
7488088, Dec 30 2002 INNOVATIONS IN OPTICS, INC. LED white light illuminator
7488101, Dec 30 2002 INNOVATIONS IN OPTICS, INC. High intensity LED array illuminator
7498734, Jun 18 2003 Toyoda Gosei Co., Ltd.; TOYODA GOSEI CO , LTD Light emitting device with wavelength converted by phosphor
7540616, Dec 23 2005 3M Innovative Properties Company Polarized, multicolor LED-based illumination source
7633093, May 05 2003 ACF FINCO I LP Method of making optical light engines with elevated LEDs and resulting product
7709811, Jul 03 2007 Light emitting diode illumination system
7746560, May 17 2006 EVIDENT CORPORATION Illumination optical system that uses a solid-state lighting element which generates white light, and an optical device equipped therewith
7832878, Mar 06 2006 INNOVATIONS IN OPTICS, INC. Light emitting diode projection system
7837348, May 05 2004 Rensselaer Polytechnic Institute Lighting system using multiple colored light emitting sources and diffuser element
7846391, May 22 2006 LUMENCOR, INC Bioanalytical instrumentation using a light source subsystem
7854514, May 19 2005 3M Innovative Properties Company Polarized, led-based illumination source
7857457, Sep 29 2006 3M Innovative Properties Company Fluorescent volume light source having multiple fluorescent species
7898665, Aug 06 2007 LUMENCOR, INC. Light emitting diode illumination system
7907271, Jun 15 2007 Novartis AG Method and system for standardizing microscope instruments
8029142, May 19 2005 3M Innovative Properties Company Polarized, LED-based illumination source
8098375, Aug 06 2007 LUMENCOR, INC.; LUMENCOR, INC Light emitting diode illumination system
8242462, Jan 23 2009 LUMENCOR, INC Lighting design of high quality biomedical devices
8258487, Jan 23 2009 LUMENCOR, INC. Lighting design of high quality biomedical devices
8263949, Jan 23 2009 LUMENCOR, INC. Lighting design of high quality biomedical devices
8279442, Aug 06 2007 LUMENCOR, INC. Light emitting diode illumination system
8309940, Jan 23 2009 LUMENCOR, INC. Lighting design of high quality biomedical devices
8389957, Jan 14 2011 LUMENCOR, INC.; LUMENCOR, INC System and method for metered dosage illumination in a bioanalysis or other system
8466436, Jan 14 2011 LUMENCOR, INC. System and method for metered dosage illumination in a bioanalysis or other system
20010055208,
20020109844,
20020127224,
20030044160,
20030095401,
20030127609,
20030160151,
20030230728,
20030233138,
20040090600,
20040247861,
20040264185,
20050062404,
20050116635,
20050146652,
20050152029,
20050184651,
20050201899,
20050248839,
20050260676,
20050263679,
20060002131,
20060030026,
20060060872,
20060060879,
20060097136,
20060114960,
20060170931,
20060237658,
20060282137,
20070053184,
20070053200,
20070058389,
20070064202,
20070086006,
20070126017,
20070211460,
20070253733,
20070262731,
20070279914,
20070279915,
20070280622,
20070281322,
20070284513,
20070297049,
20080079910,
20080224024,
20080291446,
20090122533,
20090196046,
20090268461,
20100188017,
20100237783,
20110044858,
20120106192,
20120181936,
20120181937,
20120238472,
20120252704,
20120307514,
20130099135,
CA2280398,
EP1426807,
GB943756,
GB2000173,
JP2005195485,
JP2005243973,
JP2006049814,
JP2007133435,
JP2008139796,
KR1020060055934,
WO2080577,
WO2004114053,
WO2006067885,
WO2006120586,
/
Executed onAssignorAssigneeConveyanceFrameReelDoc
Apr 11 2016LUMENCOR, INC.(assignment on the face of the patent)
Date Maintenance Fee Events
Sep 30 2020M2551: Payment of Maintenance Fee, 4th Yr, Small Entity.


Date Maintenance Schedule
May 23 20204 years fee payment window open
Nov 23 20206 months grace period start (w surcharge)
May 23 2021patent expiry (for year 4)
May 23 20232 years to revive unintentionally abandoned end. (for year 4)
May 23 20248 years fee payment window open
Nov 23 20246 months grace period start (w surcharge)
May 23 2025patent expiry (for year 8)
May 23 20272 years to revive unintentionally abandoned end. (for year 8)
May 23 202812 years fee payment window open
Nov 23 20286 months grace period start (w surcharge)
May 23 2029patent expiry (for year 12)
May 23 20312 years to revive unintentionally abandoned end. (for year 12)